Ultragenyx Pharmaceutical RARE Increase Decrease In Accounts Payable Accrued Liabilities And Other Operating Liabilities
Increase Decrease In Accounts Payable Accrued Liabilities And Other Operating Liabilities at other companies
Other financials
Where this comes from
Reported directly by Ultragenyx Pharmaceutical in its filing.
Tagged under the XBRL concept rare:IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ultragenyx Pharmaceutical's increase decrease in accounts payable accrued liabilities and other operating liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ultragenyx Pharmaceutical's increase decrease in accounts payable accrued liabilities and other operating liabilities?
- Ultragenyx Pharmaceutical (RARE) reported increase decrease in accounts payable accrued liabilities and other operating liabilities of -$57M in Q1 2026.
- How has Ultragenyx Pharmaceutical's increase decrease in accounts payable accrued liabilities and other operating liabilities changed year-over-year?
- Ultragenyx Pharmaceutical's increase decrease in accounts payable accrued liabilities and other operating liabilities decreased by 18.8% year-over-year, from -$48M to -$57M.
- What is the long-term trend for Ultragenyx Pharmaceutical's increase decrease in accounts payable accrued liabilities and other operating liabilities?
- Over 3 years (2021 to 2025), Ultragenyx Pharmaceutical's increase decrease in accounts payable accrued liabilities and other operating liabilities has grown at a -9.4% compound annual growth rate (CAGR), from $32.31M to $24M.
- What does increase decrease in accounts payable accrued liabilities and other operating liabilities mean?
- This represents the net change in obligations owed to suppliers and other service providers, as well as accrued operating liabilities. An increase indicates the company is retaining cash by delaying payments, while a decrease indicates cash outflows to settle outstanding debts. It serves as a primary indicator of the company's short-term cash management and vendor payment cycles.